CN Patent

CN115181093B — Sunvozertinib中间体的制备方法

Assigned to Chongqing Medical University · Expires 2023-04-25 · 3y expired

What this patent protects

本发明提供一种Sunvozertinib中间体化合物7的合成方法，使用易于获得且价格便宜的化合物为起始原料，经过五步反应制得Sunvozertinib中间体化合物7，反应过程不需要手性拆分，整个路线设计新颖，非常适合工业化应用。

USPTO Abstract

本发明提供一种Sunvozertinib中间体化合物7的合成方法，使用易于获得且价格便宜的化合物为起始原料，经过五步反应制得Sunvozertinib中间体化合物7，反应过程不需要手性拆分，整个路线设计新颖，非常适合工业化应用。

Drugs covered by this patent

Patent Metadata

Patent number: CN115181093B
Jurisdiction: CN
Classification: —
Expires: 2023-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Chongqing Medical University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.